Synergy Pharmaceuticals buy melinda
Start price
10.08.17
/
50%
€2.94
Target price
26.12.17
€4.06
Performance (%)
-30.06%
End price
26.12.17
€2.06
Summary
This prediction ended on 26.12.17 with a price of €2.06. Massive losses of -30.06% were the result for the BUY prediction by melinda. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Synergy Pharmaceuticals | - | - | - | - |
iShares Core DAX® | 0.611% | -2.723% | 14.325% | 14.359% |
iShares Nasdaq 100 | -0.208% | 6.703% | 37.781% | 55.710% |
iShares Nikkei 225® | 1.298% | 1.009% | 9.641% | 4.825% |
iShares S&P 500 | 0.636% | 5.035% | 30.827% | 48.685% |
Comments by melinda for this prediction
In the thread Synergy Pharmaceuticals diskutieren
pharma
FDA Entscheidung ist TRULANCE für die Behandlung von Erwachsenen mit Reizdarmsyndrom mit Verstopfung
2018.01.24
(Vom Mitglied beendet)
Stopped prediction by melinda for Synergy Pharmaceuticals
Synergy Pharmaceuticals
Start price
Target price
Perf. (%)
€0.093
14.12.18
14.12.18
€0.18
17.12.18
17.12.18
-12.79%
17.12.18
17.12.18
Synergy Pharmaceuticals
Start price
Target price
Perf. (%)
€2.02
06.03.18
06.03.18
€4.51
06.09.18
06.09.18
-17.86%
06.09.18
06.09.18
Synergy Pharmaceuticals
Start price
Target price
Perf. (%)
€3.26
10.08.17
10.08.17
€4.50
26.12.17
26.12.17
-30.06%
26.12.17
26.12.17
Synergy Pharmaceuticals
Start price
Target price
Perf. (%)
€4.10
25.03.17
25.03.17
€5.41
22.06.17
22.06.17
3.89%
22.06.17
22.06.17
Synergy Pharmaceuticals
Start price
Target price
Perf. (%)
€3.38
19.04.16
19.04.16
€3.61
07.06.16
07.06.16
8.22%
07.06.16
07.06.16
Synergy Pharmaceuticals
Start price
Target price
Perf. (%)
€2.93
02.09.14
02.09.14
€5.00
02.03.15
02.03.15
-10.93%
02.03.15
02.03.15